Repetitive intranasal administration of cholecystokinin potentiates its central nervous effects

Physiology and Behavior

Volumn 83, Issue 1 SPEC. ISS., 2004, Pages 39-45

  Denecke, Heide ^a   Meyer, Frank ^a   Feldkamp, Joachim ^b   Fritzen, Reimar ^a   Pietrowsky, Reinhard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Municipal Hospital Bielefeld   (Germany)

Author keywords

Cholecystokinin; ERP; Event related brain potentials; Humans; Nose brain pathway; P300; Slow wave

Indexed keywords

CHOLECYSTOKININ; HYDROCORTISONE; NEUROPEPTIDE;

ADULT; ALERTNESS; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; REACTION TIME; STIMULUS RESPONSE; TASK PERFORMANCE;

EID: 6344235098     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2004.07.021     Document Type: Article

References (29)

1. H. Fink, A. Rex, M. Voits, and J.P. Voigt Major biologial actions of CCKâ€"a critical evaluation of research findings Exp. Brain Res. 123 1998 77 83
2. R.S. Feldman, J.S. Meyer, and L.F. Quenzer Principles of neuropsychopharmacology 1997 Sinauer Associates Sunderland 484 490
3. J.N. Crawley, and R.L. Corwin Biological actions of cholecystokinin Peptides 15 1994 731 755
4. R. Smolnik, S. Fischer, J. Hagenah, B. Kis, J. Born, and P. Vieregge Brain potential signs of slowed stimulus processing following cholecystokinin on Parkinson's disease Psychopharmacology 161 2002 70 76
5. H. Denecke, N. Czehak, and R. Pietrowsky Doseâ€"response relationships of intranasal cholecystokinin and the P300 event-related brain potential Pharmacol. Biochem. Behav. 73 2002 593 600
6. R. Pietrowsky, L. Claassen, H. Frercks, H.L. Fehm, and J. Born Time-course of intranasally administered cholecystokinin-8 on central nervous effects Neuropsychobiology 43 2001 254 259
7. R. Pietrowsky, S. Rudolf, M. Mölle, H.L. Fehm, and J. Born Cholecystokin-induced effects on selective attention depend on level of activation Neuropsychobiology 36 1997 87 95
8. R. Pietrowsky, A. Thiemann, W. Kern, and H.L. Fehm A nosea-brain-pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin Psychoneuroendocrinology 21 1996 559 572
9. R. Pietrowsky, J. Born, W. Kern, and H.L. Fehm Functional evidence for a transmission of peptides along the olfactory systems into the brain in healthy humans B. Krisch R. Mentlein The peptidergic neuron 1996 Birkhaúser Verlag Basel, Switzerland 291 296
10. H. Schreiber, G. Stolz-Born, R. Pietrowsky, H.H. Kornhuber, H.L. Fehm, and J. Born Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons Biol. Psychiatry 37 1995 702 712
11. A. Kok On the utility of P3 amplitude as a measure of processing capacity Psychophysiology 38 2001 557 577
12. J. Polich, and K.L. Herbst P300 as a clinical assay: rationale, evaluation, and findings Int. J. Psychophysiol. 38 2000 3 19
13. D. Ravden, and J. Polich Habituation of P300 from visual stimuli Int. J. Psychophysiol. 30 1998 359 365
14. J. Polich, and A. Kok Cognitive and biological determinants of P300: an integrative review Biol. Psychol. 41 1995 103 146
15. M.D. Comerchero, and J. Polich P3a and P3b from typical auditory and visual stimuli Clin. Neurophysiol. 110 1999 24 30
16. T. Picton The P300 wave of the human event-related potential J. Clin. Neurophysiol. 9 1992 456 479
17. J. Born, T. Lange, W. Kern, G.P. McGregor, U. Bickel, and H.L. Fehm Sniffing neuropeptides: a transnasal approach to the human brain Nat. Neurosci. 5 2002 514 516
18. R. Pietrowsky, C. Str̈ben, M. Mölle, H.L. Fehm, and J. Born Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct noseâ€"brain pathway for peptide effects in humans Biol. Psychiatry 39 1996 332 340
19. C. Bargman From the nose into the brain Nature 384 1996 512 513
20. S.K. Itaya Anterograde transsynaptic transport of WGA-HRP in rat olfactory pathways Brain Res. 21 1987 205 214
21. B.J. Balin, R.D. Broadwell, M. Salcman, and M. El-Kalliny Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey J. Comp. Neurol. 251 1986 260 280
22. T.D. Geracioti Jr., W.E. Nicholson, D.N. Orth, N.N. Ekhator, and P.T. Loosen Cholecystokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in healths, depression and alcoholism Brain Res. 629 1993 260 268
23. E. Späth-Schwalbe, L. Piroth, R. Pietrowsky, J. Born, and H.L. Fehm Stimulation of the pituitary adrenocortical system in man by cerulein, a cholecystokinin-8-like peptide Clin. Physiol. Biochem. 6 1988 316 320
24. R.A. Dressendörfer, C. Kirschbaum, W. Rohde, F. Stahl, and C.J. Strasburger Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement J. Steroid Biochem. Mol. Biol. 43 1992 683 692
25. Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP), version 1.5 [battery for the assessment of attention TAP, version 1.5]. Psytest, Freiburg, 1999.
26. R. Verleger On the utility of P3 latency as an index of mental chronometry Psychophysiology 34 1997 131 156
27. V.J. Knott, C. Mahoney, T. Gunnarsson, J. Bradwejn, and J. Shlik Acute cholecystokinin effects on event-related potentials in healthy volunteers Hum. Psychopharmacol. 17 2002 285 291
28. R. Pietrowsky, H.L. Fehm, A. Er, P. Pauschinger, and J. Born Influences of the cholecystokinin analog ceruletide on human sleep and evoked potentials Neuropsychobiology 23 1990 41 47
29. R. Pietrowsky, C. Schiemann, H.L. Fehm, and J. Born The P2 amplitude of the auditory evoked potential is diminished by the cholecystokinin analog ceruletide J. Psychophysiol. 7 1993 3 10